129564 20241125101132.0 doi 10.3390/healthcare12010010 sideral 135845 ART-2023-135845 eng Javier-Ormazábal, Alberto The effectiveness of a single dry needling session on gait and quality of life in multiple sclerosis: a double-blind randomized sham-controlled pilot trial 2023 Access copy available to the general public Unrestricted Gait disorders are a major cause of disability and reduced health-related quality of life in people with multiple sclerosis (pwMS). Dry needling (DN) has demonstrated positive results to improve gait parameters in patients with stroke. The main aim of this study was to evaluate the effect of a single session of DN in the gait performance of pwMS. Methods: A double-blind parallel randomized sham-controlled pilot trial was conducted. Study participants received a single session of active DN or sham DN in the gastrocnemius medialis muscle. Pre-treatment and immediately post-treatment measurements were taken, as well as at one and four weeks after the intervention. Outcomes related to gait performance (Timed 25-Foot Walk), self-perceived walking capacity (Multiple Sclerosis Walking Scale), risk of falls (Timed Up and Go test), disability level (Expanded Disability Status Score) and quality of life (Multiple Sclerosis Quality of Life-54 questionnaire and Analogic Quality of Life scale) were evaluated. Results: 18 patients who had multiple sclerosis participated in the study. The group who received active DN showed within-group significant statistical differences immediately after treatment for gait performance (p = 0.008) and risk of falls (p = 0.008), as well as for self-perceived walking capacity at one week (p = 0.017) and four weeks (p = 0.011) and quality of life at four weeks (p = 0.014). Regarding the comparison between groups, only significant results were obtained in the physical domain of the quality of life at four weeks (p = 0.014). Conclusions: DN seems to be a promising therapeutic tool for the treatment of gait disorders in pwMS. However, when results were compared with sham DN, no differences were found. info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 2.4 2023 HEALTH POLICY & SERVICES 49 / 118 = 0.415 2023 Q2 T2 HEALTH CARE SCIENCES & SERVICES 73 / 174 = 0.42 2023 Q2 T2 0.606 2023 Health Policy 2023 Q2 Leadership and Management 2023 Q2 Health Informatics 2023 Q3 Health Information Management 2023 Q3 3.5 2023 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion González-Platas, Montserrat Jiménez-Sosa, Alejandro Herrero, Pablo Universidad de Zaragoza (orcid)0000-0002-9201-0120 Lapuente-Hernández, Diego Universidad de Zaragoza (orcid)0000-0002-6506-6081 1006 413 Universidad de Zaragoza Dpto. Fisiatría y Enfermería Área Fisioterapia 12, 10 (2023), 1-12 Healthcare (Basel) Healthcare (Switzerland) 2227-9032 1737055 http://zaguan.unizar.es/record/129564/files/texto_completo.pdf Versión publicada 2768499 http://zaguan.unizar.es/record/129564/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:129564 articulos driver 2024-11-22-11:59:13 ARTICLE